Neonatal apnea and gastroesophageal reflux (GER): Is there a problem?

Early Human Development

Volumn 89, Issue SUPPL.1, 2013, Pages

  Jawdeh, Elie G Abu ^a,b   Martin, Richard J ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Acid suppression therapy; Low esophageal sphincter relaxation; Respiratory control

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; PLACEBO; PROTON PUMP INHIBITOR; RANITIDINE; XANTHINE DERIVATIVE;

BRADYCARDIA; CATHETERIZATION; CHILDHOOD DISEASE; CLINICAL PRACTICE; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS PH; EXTREMELY LOW BIRTH WEIGHT; GASTROESOPHAGEAL REFLUX; HUMAN; HYPOXIA; IMPEDANCE; LOWER ESOPHAGUS SPHINCTER; NEWBORN APNEA; NONHUMAN; PLETHYSMOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PREMATURITY; RESPIRATION CONTROL; RESPIRATION DEPRESSION; REVIEW;

APNEA; ESOPHAGEAL PH MONITORING; ESOPHAGEAL SPHINCTER, LOWER; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MUSCLE RELAXATION; PROTON PUMP INHIBITORS; TIME FACTORS;

EID: 84879808030     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/S0378-3782(13)70005-7     Document Type: Review

References (19)

1. Malcolm WF, Gantz M, Martin RJ, Goldstein RF, Goldberg RN, cotten CM Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants. Pediatrics 2008, 121(1):22-27.
2. Dhillon AS, Ewer AK Diagnosis and management of gastro-oesophageal reflux in preterm infants in neonatal intensive care units. Acta Paediatr 2004, 93(1):88-93.
3. Golski CA, Rome ES, Martin RJ, Frank SH, Worley S, Sun Z, et al. Pediatric specialists' beliefs about gastroesophageal reflux disease in premature infants. Pediatrics 2010, 125(1):96-104.
4. Abu Jawdeh EG, O'Riordan MA, Limrungsikul A, Bandyopadhyay A, Argus BM, Nakad PE, et al. Prevalence of prophylactic caffeine use among an international cohort of neonatologists, 2012: Pediatric Academic Societies (PAS) Annual Meeting.
5. Diaz DM, Winter HS, Colletti RB, Ferry GD, Rudolph CD, Czinn SJ, et al. Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2007, 45(1):56-64.
6. Slocum C, Hibbs AM, Martin RJ, Orenstein SR Infant apnea and gastroesophageal reflux: a critical review and framework for further investigation. Curr Gastroenterol Rep 2007, 9(3):219-224.
7. Abu-Shaweesh JM, Dreshaj IA, Haxhiu MA, Martin RJ Central GABAergic mechanisms are involved in apnea induced by SLN stimulation in piglets. J Appl Physiol 2001, 90(4):1570-1576.
8. Davies AM, Koenig JS, Thach BT Characteristics of upper airway chemoreflex prolonged apnea in human infants. Am Rev Respir Dis 1989, 139(3):668-673.
9. Kiatchoosakun P, Dreshaj IA, Abu-Shaweesh JM, Haxhiu MA, Martin RJ Effects of hypoxia on respiratory neural output and lower esophageal sphincter pressure in piglets. Pediatr Res 2002, 52(1):50-55.
10. Omari TI Apnea-associated reduction in lower esophageal sphincter tone in premature infants. J Pediatr 2009, 154(3):374-378.
11. Corvaglia L, Zama D, Gualdi S, Ferlini M, Aceti A, Faldella G Gastro-oesophageal reflux increases the number of apnoeas in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2009, 94(3):F188-F192.
12. Di Fiore J, Arko M, Herynk B, Martin R, Hibbs AM Characterization of cardiorespiratory events following gastroesophageal reflux in preterm infants. J Perinatol 2010, 30(10):683-687.
13. Martin RJ, Di Fiore JM, Hibbs AM Gastroesophageal reflux in preterm infants: is positioning the answer?. J Pediatr 2007, 151(6):560-561.
14. Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009, 154(4):514-520. e4.
15. Guillet R, Stoll BJ, Cotten CM, Gantz M, McDonald S, Poole WK, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006, 117(2):e137-e142.
16. Terrin G, Passariello A, De Curtis M, Manguso F, Salvia G, Lega L, et al. Ranitidine is associated with infections, necrotizing enterocolitis, fatal outcome in newborns. Pediatrics 2012, 129(1):e40-e45.
17. Wheatley E, Kennedy KA Cross-over trial of treatment for bradycardia attributed to gastroesophageal reflux in preterm infants. J Pediatr 2009, 155(4):516-521.
18. Hibbs AM Pharmacology Review: Pharmacotherapy for gastroesophageal reflux disease. Neoreviews 2011, 12(3):e159-e166.
19. Cresi F, Locatelli E, Marinaccio C, Grasso G, Coscia A, Bertino E Prognostic values of multichannel intraluminal impedance and pH monitoring in newborns with symptoms of gastroesophageal reflux disease. J Pediatr 2013, 162(4):770-775.